From Yahoo Finance: 2025-06-13 20:56:00

Intuitive Surgical, a leader in robotic surgery, integrates AI into healthcare with its da Vinci 5 system, offering a new revenue stream. Despite stock below all-time high, its market share remains strong at 60%. Competitors like Medtronic and Johnson & Johnson enter the robotic surgery space, but Intuitive Surgical’s first-mover advantage and innovation keep it ahead.

The da Vinci 5 system provides advanced AI capabilities, enhancing surgical outcomes. While competition intensifies, Intuitive Surgical’s profitability, R&D investment, and brand trust position it well. Concerns include valuation, external pressures, and regulatory shifts. Nonetheless, the company’s long-term potential in the evolving surgical robotics market remains promising.

Analyst Brandon Vazquez maintains a Buy rating on Intuitive Surgical, addressing concerns over third-party remanufactured instruments. The launch of da Vinci 5 solidifies Intuitive Surgical’s position in the AI-driven robotic surgery market. Despite risks, the company’s leadership and innovation make it a compelling long-term investment.

Read more: Healthcare Sector Taps AI Boom via Intuitive Surgical Stock (ISRG)